Vaginal Pessary Versus Expectant Management for Placenta Previa
Public ClinicalTrials.gov record NCT01996345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Vaginal Pessary Versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women With Placenta Previa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to perform a large multi-center randomized trial comparing the role of vaginal pessary versus expectant management in women with placenta previa between 22w0d and 32w0d of gestation in prolonging gestation until ≥36 weeks. Secondary outcomes will assess duration of antepartum admission, total blood loss, gestational age at delivery, type of cesarean delivery, and a composite neonatal outcome. The hypothesis is that the use of a vaginal pessary in patients presenting with placenta previa between 22-32 weeks will decrease delivery prior to 36 weeks as compared to expectantly managing these patients.
Study identification
- NCT ID
- NCT01996345
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 54 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2016 (Actual)
- Primary completion
- Sep 5, 2018 (Actual)
- Completion
- Sep 5, 2018 (Actual)
- Last update posted
- Sep 27, 2018
2016 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Medical Center | Mobile | Alabama | 36617 | — |
| Long Beach Memorial Medical Center | Long Beach | California | 90801-1428 | — |
| Good Samaritan Hospital | San Jose | California | 95008 | — |
| Presbyterian/St Luke's Hospital | Denver | Colorado | 80218 | — |
| Denver Health and Hospital Authority | Denver | Colorado | 95008 | — |
| Norton Kosair Children's Hospital | Louisville | Kentucky | 40202 | — |
| Tulane - Lakeside Hospital for Women and Children | Metairie | Louisiana | 70001 | — |
| Touro Infirmary | New Orleans | Louisiana | 70115 | — |
| Baylor/Texas Children's Hospital & Pavilion | Houston | Texas | 77030 | — |
| Swedish Medical Center | Seattle | Washington | 98122-4307 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01996345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2018 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01996345 live on ClinicalTrials.gov.